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In order to cope with the exponentially increasing number of patients infected
with SARS-CoV-2, European countries made enormous efforts to reorganize
medical assistance and several diseases, including stroke, were particularly
impacted. We report the experience of stroke neurologists from three Euro-
pean countries (Italy, France and Germany) that faced the pandemic at
diverse time points and with different approaches, depending on their
resources and healthcare system organization. Pre-hospital and in-hospital
acute stroke pathways were reorganized to prioritize COVID-19 management
and, in severely affected regions of Italy and France, stroke care was central-
ized to a limited number of centers, whereas the remaining stroke units were
dedicated to patients with COVID-19. Access to acute stroke diagnostics and
time-dependent therapies was limited or delayed because of reduced capacities
of emergency services due to the burden of patients with COVID-19. A
marked reduction in the number of patients presenting with transient ischae-
mic attack and stroke was noted in the emergency departments of all three
countries. Although we only have preliminary data, these conditions may have
affected stroke outcome. These indirect effects of the COVID-19 pandemic
could negate the efforts of stroke neurologists over the last few years to
improve outcome and reduce mortality of stroke patients. Although the
SARS-CoV-2 infection rate is slowing down in Europe, the effects of ending
lockdown in the next months are unpredictable. It is important for the Euro-
pean and world stroke community to share what has been learned so far to be
plan strategies to ensure stroke care in the future and upcoming challenging
times.
Introduction
As of 21 May 2020, the spread of the SARS-CoV-2
disease (COVID-19) has reached pandemic propor-
tions, affecting more than 5 011 000 people worldwide
[1]. Although the majority of cases were first reported
in China, soon thereafter Europe became the disease
epicenter with Spain and Italy leading the list of
countries with the highest number of COVID-19
cases, followed by France and Germany [1]. Since the
beginning of the outbreak, European countries have
adopted unprecedented measures such as large-scale
application of social isolation, closing borders and
nationwide lockdown at great economic cost. In addi-
tion, some extreme healthcare reorganizations have
been implemented in several countries to fight against
COVID-19, with different time lags and approaches,
also in relation to national healthcare system organi-
zation and resources [2,3]. The impellent turning of
health staff and hospital resources towards the
Correspondence: A. Bersano, Cerebrovascular Unit, Fondazione
IRCCS Istituto Neurologico Carlo Besta, via Celoria 11, Milan Italy
(tel.: +390223943310; fax: +390223943312; e-mail:
anna.bersano@gmail.com).
© 2020 European Academy of Neurology1794
R E V I E W A R T I C L E
E
U
R
O
P
E
A
N
J
O
U
R
N
A
L
O
F
N
E
U
R
O
L
O
G
Y
COVID-19 emergency is inevitably leading to a seri-
ous impairment of normal medical care, particularly
for diseases such as stroke, which is the second most
common cause of death and the leading cause of dis-
ability [4]. Moreover, patients affected by COVID-19
have been hypothesized to be at increased risk of cere-
brovascular events, probably due to the infection itself
but also thrombotic complications [5–7]. A tlast ele-
ment to be possibly considered is that patients with
cerebrovascular diseases might also be at major risk
of developing severe consequences from COVID-19
infections [8].
Herein, we report the experience and issues faced in
stroke care organization in three European countries
(Italy, France, Germany) during the COVID-19 pan-
demic. Although, as of today, the spreading curve of
infection is slowly flattening, the COVID-19 pandemic
is persisting in light of the end of lockdown. Report-
ing these experiences and highlighting problems may
offer scope for discussion and for the development of
potential strategies to ensure the adequate care of
stroke patients in present and future challenging
times.
The Italian experience
Beginning in mid-February 2020, the Italian authori-
ties, particularly the regional health services (which in
Italy have considerable autonomy from the central
government on healthcare issues), had to manage a
huge reorganization to direct resources towards the
care of patients with COVID-19 [9]. On 21 May, the
Johns Hopkins University counted 227 364 diagnosed
COVID-19 infections and 32 330 (14.2%) deaths in
Italy [1]. The rapid surge of COVID-19 cases seriously
threatened the Italian health system. The intensive
care unit (ICU) beds (about 5100 in the pre-COVID-
19 era, with an occupation rate of 48.4%) became
almost completely dedicated to patients with COVID-
19. New ICUs were created, increasing the number of
ICU beds to 8800 [10]. Protective measures, including
indications for personal protective equipment and
swab testing, were also progressively released accord-
ing to regional indications. Many regions such as
Lombardia, which is (with >10 million inhabitants)
the largest in Italy, and also the region with the high-
est number of COVID-19 cases, decided to dedicate
entire hospitals to the increasing needs of COVID-19-
positive patients. In contrast, the care of non-COVID-
19 diseases as well as non-urgent interventions and
outpatient activities were greatly reduced or even
stopped [11–13].
Acute stroke pathways were also completely
redrawn: pre-hospital transportation was reorganized
to prioritize the needs of patients infected with SARS-
CoV-2 and specific triage protocols were activated to
assess and manage COVID-19 suspicion or infection.
Many stroke units were closed to reallocate stroke
physicians and nurses to the care of patients with
COVID-19 or were even converted into COVID-19-
positive wards [9,13,14]. Therefore, the usual hub-and-
spoke system underwent an upheaval and all patients
started to be primarily directed towards a limited
number of centers where they were supposed to
remain until discharge [11,13,14]. The result of this
measure was to concentrate many stroke patients
from huge areas in a limited number of hospitals,
according to regional location and availability of beds
and thrombectomy equipment. The Lombardia region
retained 11 stroke centers from the previous 36
regionally certified stroke units. In the remaining cen-
ters, stroke management was limited to emergency
care and patients were hospitalized in non-stroke-unit
beds intermingled with other patients. In hub centers,
dedicated areas for non-COVID-19 and COVID-19-
positive patients were organized and adequate isola-
tion measures for COVID-19-positive patients treated
in stroke units were implemented. However, it was
difficult to completely separate the pathways due to a
considerable number of stroke patients identified as
COVID-19 positive in the course of their hospital
stay. Therefore, all stroke patients presenting to the
emergency department were finally regarded as possi-
bly infectious and were isolated. In addition to the
usual computed tomography (CT) brain scan and CT
angiography, these patients underwent chest X-ray or
CT scan, extended biochemistry and infectious disease
physician consultation. In acute care, the multidisci-
plinary team was maintained but with consultations
being greatly limited by the physician shortage. More-
over, the availability of ancillary examinations such as
brain magnetic resonance imaging or angiography for
stroke patients was hampered by the need to keep
diagnostic services protected and to manage patients
with COVID-19.
Although this reorganization was accompanied by
the effort of increasing the number of beds and the
availability of personnel in some of these newly
defined stroke hub centers, these changes probably
influenced the availability of timely reperfusion thera-
pies and emergency pathways for stroke patients [13–
15]. Given the overcrowding of emergency rooms in
these centers, the personnel shortage and the need for
screening procedures as well as multidisciplinary con-
sultations (i.e. infectious disease physicians, anes-
thetists), modified algorithms for patients presenting
with large vessel occlusion were implemented, also
including safety measures for the medical team and
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patients. As yet, we have no data about the current
onset-to-needle time in Italy, but it is likely that it has
increased due to the heavy workload of the ambulance
and emergency operators, time required for COVID-
19 screening procedures and flooding of emergency
rooms with patients with respiratory symptoms [13–
16].
Post-stroke rehabilitation pathways were also cen-
tralized, due to the need to allocate wards to COVID-
19 acute management, and rehabilitation care and ser-
vices were divided into COVID-19-free and COVID-
19-positive areas to guarantee adequate measures for
patient isolation.
Similar to observations in cardiovascular disease, a
stroke survey on 81 Italian stroke centers conducted
by the Italian Stroke Organization [17] reported a
reduction of about 26–30% of the hospitalization rate
for minor stroke and transient ischaemic attack
(TIA), and of about 50% of stroke acute therapies in
comparison with the same period in 2019 [13,14,17].
Fear of in-hospital infection and advice from health
authorities, media and doctors probably led patients
with mild symptoms to stay at home. For this reason,
information campaigns, encouraging patients to pre-
sent early to the emergency room, have recently been
increasingly implemented by stroke physicians [18].
Periodic follow-up visits, previously planned proce-
dures and rehabilitation services for stroke survivors
have been cut down in Italy due to restrictive mea-
sures implemented to reduce the spread of COVID-19
[9,13]. This raised the question of how to take care of
patients who need periodic consultations and/or reha-
bilitation support. To overcome these limitations,
some patients were contacted by telephone and tele-
medicine platforms were implemented to allow patient
visits, thus avoiding direct contact with operators and
waiting rooms [19–21].
The French experience
On 21 May 2020 in France, 181 700 infections and
28 135 (15.5%) deaths had been reported [1]. On 6
March, the French government launched the emer-
gency plan called ‘plan blanc’ for hospitals. As a
result, many hospital beds and staff were reallocated
to patients with COVID-19 infection or suspected
infection. In normal conditions, there are about 5000
ICU beds (with ventilator) in France. Due to the pan-
demic, the number of beds has rapidly increased to
about 10 000 (7200 of which were dedicated to
patients with COVID-19) and this increase was partic-
ularly important in some areas (where ICU bed num-
bers were increased by two- or threefold in a few
weeks). Moreover, routine medical consultations were
cancelled. Each hospital had to define its own gradual
charge depending on the number of patients with
COVID-19 who were admitted. A rapid decrease in
admissions for acute stroke was observed in almost all
stroke units, including those eligible for recanalization
therapies. However, at this stage, no systematic inves-
tigation is available for France [16]. As the spread of
the epidemic was heterogeneous across the country,
we observed various consequences. The most affected
areas in France were the Great East, Paris and its
suburbs and, to a lesser extent, the North. In these
areas, some stroke units were initially entirely con-
verted into ICUs. Although rarely, stroke neurologists
and nurses were redeployed to work on these
COVID-19-dedicated units. This redeployment was
feasible because routine medical visits by chronic
patients were cancelled and non-urgent hospitaliza-
tions were postponed, and also because of the help
and availability of other neurologists and nurses from
non-stroke neurological departments. Thus, at the
beginning of the crisis, acute stroke patients were
managed in non-dedicated beds intermingled with
non-stroke patients, with daily visits from stroke neu-
rologists and nurses and staff who were not stroke
specialists. However, after a few weeks, in the major-
ity of the stroke centers in Paris, stroke units were
restored and divided into two separate areas, one for
confirmed or suspected COVID-19 and one for non-
COVID-19 stroke patients. It still remains to be deter-
mined whether this reorganization has had conse-
quences in terms of delays, use of acute treatments
and prognosis. At the end of March 2020, the French
Neurovascular Society and French Society of Neuro-
radiology published recommendations for manage-
ment of patients with acute stroke in the context of
the pandemic stating that acute stroke patients could
be managed with thrombolysis and mechanical
thrombectomy whether or not they had a COVID-19
infection [22]. Early in April, a joint press release
(French Neurovascular Society and French Society of
Cardiology) was published to alert all professionals
and the population that management of acute stroke
and acute coronary events was still organized and safe
[23]. This campaign encouraged the population to
alert emergency services in case of symptoms and
explained that patients with and without COVID-19
were managed in separate hospitals or pathways in
the same hospital, depending on the local environ-
ment.
The main concerns in France about the manage-
ment of acute stroke patients were delays in calling
emergency services after first symptoms, potential
unavailability of anesthetists for patients requiring
mechanical thrombectomy and delay in brain imaging
© 2020 European Academy of Neurology
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due to the need for disinfection procedures in contam-
inated CT rooms. In post-stroke management, as all
routine visits were cancelled, physicians tried to con-
tact patients by telephone or using telemedicine plat-
forms. In addition, patients with a physical disability,
speech disorders or cognitive impairment had difficul-
ties in starting out-of-hospital rehabilitation due to
the low availability of physiotherapists or speech ther-
apists who had to close their offices. With regard to
preventive drugs, the French government has allowed
pharmacists to extend the delivery of drugs without
the need for a new prescription. Finally, we observe
that, fortunately, a large number of patients with
COVID-19 can be discharged from the ICU. How-
ever, some patients have pulmonary and sometimes
neurological (especially critical illness polyneuropathy
and myopathy) symptoms and will require rehabilita-
tion services, which may result in fewer beds being
available for stroke patients. However, as non-urgent
surgical interventions have been postponed, more
post-surgery rehabilitation beds may be available.
The German experience
Before the SARS-CoV-2 pandemic, there were 28 000
ICU beds with 20 000 ventilator devices across all
medical departments available for 83 million German
inhabitants [24].
On 21 May, Germany reported 178 545 COVID-19
infections and 8172 deaths (4.6%) [1]. On 21 April
2020, 2908 patients with COVID-19 were being trea-
ted in ICUs with 2112 of them on ventilation. At that
time, 31 244 ICU beds were available, with 12 623
(40.4%) beds being vacant [25]. The German Ministry
of Health together with the Health Ministries of the
16 federal German states recommended on 16 March
that all predictable treatments and operations should
be postponed to increase ICU capacities for the
expected rising numbers of patients with COVID-19.
Most emergency units were organized with specific
separated rooms for patients with suspected COVID-
19 infection. Routine medical consultations were can-
celled and sick certificates are being requested by tele-
phone or video calls, whereas general practitioners,
neurologists, physiotherapists and speech therapists
continued to assist patients. To the best of our knowl-
edge, there was no major reorganization of the stroke
care system in Germany, including 332 certified stroke
units. Most stroke units were not closed or trans-
formed into ICUs for patients with COVID-19, except
for a few hospitals with stroke units that were tem-
porarily not able to admit new patients due to a clus-
tered COVID-19 infection among patients and
medical staff [26].
On 2 April, the Cerebrovascular Diseases commis-
sion of the German Society of Neurology stated that
acute treatment of stroke patients, secondary preven-
tion and rehabilitation should be performed as
‘smoothly and optimally’ as possible [26].
To date, there are no articles published by German
authors that have systematically investigated changes in
TIA/stroke patients and treatment rates due to the
SARS-CoV-2 pandemic. However, based on the shared
experience of stroke neurologists in the Neurovascular
Network Ruhr, covering 27 stroke units and nine neuro-
interventional centers in a metropolitan area with 5.2
million inhabitants, a marked decrease of patients with
TIA and minor stroke presenting at emergency room
was noted. Some stroke centers also reported substan-
tially decreased numbers of stroke patients receiving
mechanical thrombectomy. In the Alfried Krupp Hospi-
tal Essen (neuro-interventional stroke center with
approximately 1000 stroke patients per year), the num-
ber of patients presenting with TIA markedly decreased
by 45% during the 5 weeks of lockdown from 16 March
to 19 April compared with the two 5-week periods
before the lockdown and the previous year’s 5-week per-
iod. In contrast, neither the number of patients hospital-
ized for ischaemic strokes or intracerebral hemorrhages
nor the number of patients receiving intravenous throm-
bolysis or mechanical thrombectomy changed. A public-
ity campaign initiated by the German Society of
Neurology and German Stroke Society on 14 April
about the so-called ‘phenomenon of empty stroke units’
in television and newspapers began to animate patients
to seek medical help [27].
Due to more capacity in rehabilitation clinics and
reduced authorization periods by health insurers, Ger-
man stroke neurologists observed markedly reduced
time intervals for transfer of acute stroke patients
from stroke units directly to rehabilitation clinics.
Discussion
The current COVID-19 crisis has not only affected
directly infected patients, but has also had multiple and
profound implications for healthcare systems world-
wide, in particular for patients with cardiovascular and
cerebrovascular diseases, the two leading causes of
death. In this article, we report the impact of the
COVID-19 outbreak on stroke care in three different
European countries. The three countries faced the pan-
demic with different time lags and with diverse orga-
nized healthcare systems. Although our report lacks
systematic data in this exceptional and unpredictable
situation, the experience in the three European coun-
tries may be helpful in order to be better prepared in
future for new challenging situations.
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In all three countries, the COVID-19 pandemic
resulted in an adjustment of the emergency pathways
and clinical inpatient and outpatient services [16]. In
Italy and France, which were hit harder and, in the case
of Italy, earlier compared with Germany, the most
important organizational change for patients with cere-
brovascular diseases was the centralization of acute
stroke treatment in a limited number of hospitals and
the partial reallocation of stroke unit beds into interme-
diate or intensive care beds. Multidisciplinary team
management was also limited in the three countries.
Another important issue is that, contrary to what
was expected from centralization strategies and from
the observed increased risk of stroke in patients with
COVID-19, the number of TIA and stroke patients
accessing the emergency pathways was unanimously
reported to be greatly reduced in comparison to the
same period in 2019 in all three countries [6]. This phe-
nomenon was observed in most European countries
[16], as stated in the reports of the European Stroke
and Neurological Societies (i.e. European Stroke
Organisation, World Stroke Organization, European
Academy of Neurology). The most likely explanation is
that patients with mild stroke or TIA stayed at home
due to the lockdown measures and general advice
not to leave their house as doctors and media cam-
paigns advised people to limit emergency room visits
[13,28,29]. Furthermore, in Italy and France, older
patients from nursing homes or rehabilitation clinics
with very severe strokes and high pre-existing disability
might also not be hospitalized because of the lack of
stroke unit or ICU beds. Moreover, due to the contact
ban and lack of social contact with relatives, neighbors
and friends, symptoms like dysarthria, aphasia, neglect
or mild paresis could be under-recognized by the
patients themselves. Stroke signs might also not be
diagnosed in patients hospitalized for pulmonary
symptoms due to COVID-19 protective measures and
missing neurological examination. Patients with cere-
brovascular risk factors such as hypertension, diabetes,
previous cardiovascular and cerebrovascular diseases
are at major risk of severe COVID-19 illness and could
have been hospitalized in ICUs for pulmonary prob-
lems, without a diagnosis of stroke.
In addition, access to time-dependent stroke ther-
apy has been severely limited or delayed by reduced
transportation capacities and busy emergency and CT
services due to the burden of patients with COVID-
19, mostly in those countries that could not be pre-
pared in time for the exponentially rising numbers of
patients with COVID-19.
Finally, outpatient visits by stroke survivors have
been greatly reduced in France, Italy and Germany,
whereas rehabilitation activities were continued
differently. Although several hospitals increasingly
started to use telemedicine platforms, this type of
assistance might not be the best solution for the gen-
erally old population of stroke patients and is proba-
bly insufficient to take care of the large population of
patients with chronic cerebrovascular diseases.
This article is limited by lack of systematic data on
acute stroke treatment and outcome and by the miss-
ing information on stroke care organization from
other European nations, including Spain, which was
amongst the earliest and most severely hit countries.
We believe that this contingent ‘suspended life’ [29]
might result in a higher risk of stroke occurrence or
recurrence and a lower adherence to secondary pre-
vention and rehabilitation treatments, exposing
patients to a higher risk of recurrent cerebrovascular
events, increased disability and, last but not least, psy-
chological consequences. This indirect effect of the
COVID-19 pandemic could negate the effects of previ-
ous successful awareness campaigns designed to
emphasize the importance of early presentation in case
of acute neurological deficits and the efforts of stroke
neurologists over the last few years to improve func-
tional outcome and reduce mortality in stroke patients
[14]. It is quite alarming that COVID-19 infection
may shorten life expectancy in our most elderly stroke
patient population, not only directly by the infection
itself. For this reason, public awareness campaigns
have been started by local initiatives and international
stroke societies (i.e. European Academy of Neurology,
European Stroke Organisation, World Stroke Organi-
zation, American Heart Association [AHA]) to
emphasize the importance of early presentation in
emergency rooms in the case of stroke symptoms.
A last important remark concerns the protection of
patients but also medical staff from in-hospital
COVID-19 infection [4,30]. Many health professionals
were infected and died during the pandemic. A num-
ber of protection strategies were applied to prevent
transmission of pathogens to health professionals or
other hospital patients. Some hospitals were reorga-
nized into COVID-19-positive and COVID-19-free
areas to prevent unnoticed virus transmission among
patients and health staff and to guarantee that a num-
ber of services continued to work. Screening strate-
gies, hospital admission protocols and prevention
measures were adopted in different ways according to
national or local health policies. In contrast to Italy
and France, which were among the first European
countries to be infected and also suffered an earlier
depletion of surgical masks and personal protective
equipment, Germany adopted swab testing and pro-
tection strategies earlier in the course of the nation-
wide pandemic.
© 2020 European Academy of Neurology
1798 A. BERSANO ET AL.
It is currently being discussed whether extensive
screening is feasible and applicable to all stroke
patients presenting at the emergency room and
whether this will be useful when lockdown measures
are relaxed in the upcoming weeks. Systematic screen-
ing procedures may introduce delays in admission to
stroke units and investigations, in addition to requir-
ing dedicated pathways, beds (i.e. single rooms) and
waiting rooms.
In conclusion, the COVID-19 pandemic has
resulted in great alterations in the acute and follow-
up management of stroke patients. Although the con-
trol of infection is very important, it is crucial that
stroke physicians are able to continue caring for their
patients. As pointed out before, it is important to bal-
ance the demands of a global pandemic, limiting
nosocomial virus spreading and optimizing acute care
resources, and the maintenance of access to outpa-
tient and inpatient stroke services [4]. Hospital admin-
istrators and health system authorities should be
reminded that stroke care is dependent on specialized
and multidisciplinary teams and stroke physicians
should be not removed from the care of stroke
patients. Another challenging task for stroke physi-
cians is to ensure care for ongoing medical and non-
medical secondary prevention and rehabilitation ther-
apy for their patients.
Political leaders and health authorities should get
into or stay in close contact with physicians to main-
tain the best possible treatment of acute stroke
patients and sroke survivors by careful planning
strategies without forgetting investment in research,
education and training [4]. The results from ongoing
prospective and retrospective observational studies in
stroke patients will be helpful to further direct stroke
treatment in this challenging situation. Given the
heterogeneous strategies applied in different countries,
we recommend information and scientific exchanges
by using existing and establishing new national and
international stroke networks [16].
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